Alzheimer's Disease Clinical Trials in San Antonio

Showing 41-60 of 91 trials

ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease

NCT02817906

This is a randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ITI-007 versus placebo administered orally once daily in the treatment of agitation in patients with dementia, including Alzheimer's disease.

Agitation in Dementia, Including Alzheimer's Disease

Intra-Cellular Therapies, Inc.177 participantsStarted Aug 2016

Sun City, Arizona, United States • Little Rock, Arkansas, United States • Rogers, Arkansas, United States +23 more locations

TERMINATEDPHASE3< 1 mile

2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)

NCT02916056

This is an open-label extension study in patients with mild Alzheimer's disease who have completed participation in the azeliragon Phase 3 (STEADFAST) trial. Patients will receive azeliragon 5 mg/day for up to 2 years.

Alzheimer's Disease

vTv Therapeutics297 participantsStarted Dec 2016

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +68 more locations

ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease

2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)

Alzheimer's Disease Trials in Other Cities

18F-AV-1451 Autopsy Study

A Study of Gantenerumab in Participants With Mild Alzheimer Disease

A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease

To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.

Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease

Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease

Study Evaluating the Safety, Tolerability, and Efficacy of Lecozotan SR in Outpatients With Alzheimer's Disease

Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease

Single-Ascending-Dose Study of BIIB076 in Healthy Volunteers and Participants With Alzheimer's Disease

Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease

Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type

A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection

Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance

Multiple Dose Safety Study of NPT088 in Patients With Mild to Moderate Probable Alzheimer's Disease

Cognitive, Behavioral, and Functional Change in Behavioral Variant Frontotemporal Dementia (bvFTD)

A Study of Brain Aging in Vietnam War Veterans

Neuro RX Gamma - Pivotal Phase

Other Conditions in San Antonio